According to a new report published by Allied Market Research, titled, “Gene Editing Tool Market By Type (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nuclease (TALEN), Zinc Finger Nuclease (ZFN), and Others), Application (Clinical Therapy, Diagnostics, Veterinary Medicine, Cell Line Engineering, Bioremediation, Food and Brewing Development, and Others), and End User (Biotech & Pharma Companies, Clinical Research Organizations, Academic & Research Institutes, and Others), Global Opportunity Analysis and Industry Forecast, 2019-2026″
The global market size of Gene Editing Tool is $XX million in 2018 with XX CAGR, and it is expected to reach $XX million by the end of 2026 with a CAGR of XX% from 2019 to 2026.
Download Free Report Sample (320 Pages PDF with Insights) @ www.alliedmarketresearch.com/request-sample/5677
Gene editing, or genome editing, is a type of genetic engineering in which with the help of engineered nucleases, DNA is inserted, deleted, or replaced in the genome of a living organism. These engineered nucleases, also known as molecular scissors, are the gene editing tools that are used to create site-specific double-strand breaks (DSBs) at desired locations in the genome. The induced double-strand breaks are then repaired through nonhomologous end joining or homologous recombination, resulting in targeted mutations. Such gene editing approach find its application in genetic engineering ranging from genetically modifying of plants for better quality to cure certain genetic disorders associated with animals and humans. Exhaustive research and development in genetic engineering has led to development of much powerful gene editing tools exhibiting high specificity, low off-target effects, and easy construction of DNA-binding domains.
The emergence of these gene editing tools has resulted in significant interest in the biomedical community. CRISPR-Cas9is one of the gene editing tools, which has been gaining tremendous interest in the scientific community due to its faster, cheaper, more accurate, and more efficient application than the other existing gene editing tools.
The gene editing tool market is segmented on the basis of type, application, and end user.
Based on type, the market is segmented into clustered regularly interspaced short palindromic repeats (CRISPR), transcription activator-like effector nuclease (TALEN), zinc finger nuclease (ZFN), and others.
The applications covered in the study include clinical therapy, diagnostics, veterinary medicine, cell line engineering, bioremediation, food & brewing development, and others.
By end user, the market is categorized into biotech & pharma companies, clinical research organizations, academic & research institutes, and others.
Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Inquire before buying @ www.alliedmarketresearch.com/purchase-enquiry/5677
The Major Key Players Are:
Thermo Fischer Scientific, Inc., Horizon Discovery Group plc, Merck KGaA, Genscript Biotech Corporation, Sangamo Therapeutics, Inc., Lonza Group AG, Editas Medicine, New England Biolabs, Origene Technologies, Inc., and CRISPR Therapeutics AG.
The other players in the value chain includes:
Transposagen Biopharmaceuticals, Inc., Integrated DNA Technologies, Inc., Takara Bio Inc., Intellia Therapeutics, and others
Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060